Albumin and alfa1-acid glycoprotein: old acquaintances

Result code in IS VaVaI
<a href="https://www.isvavai.cz/riv?ss=detail&h=RIV%2F60162694%3AG44__%2F13%3A43874861" target="_blank" >RIV/60162694:G44__/13:43874861 - isvavai.cz</a>
Result on the web
<a href="http://informahealthcare.com/doi/abs/10.1517/17425255.2013.790364" target="_blank" >http://informahealthcare.com/doi/abs/10.1517/17425255.2013.790364</a>
DOI - Digital Object Identifier
<a href="http://dx.doi.org/10.1517/17425255.2013.790364" target="_blank" >10.1517/17425255.2013.790364</a>

Result language
angličtina
Original language name
Albumin and alfa1-acid glycoprotein: old acquaintances
Original language description
Albumin and alfa1-acid glycoprotein (AGP) are two of the most abundant proteins found in plasma. Their effect on the pharmacokinetic profile of exogenous compounds has major implications to clinical practice. Recent exploration into their possible role as diagnostic markers underlines their significance, and provides highlights their potential in medicinal applications.
Czech name
—
Czech description
—

Type
J<sub>x</sub> - Unclassified - Peer-reviewed scientific article (Jimp, Jsc and Jost)
CEP classification
FR - Pharmacology and apothecary chemistry
OECD FORD branch
—

Project
<a href="/en/project/GAP303%2F11%2F1907" target="_blank" >GAP303/11/1907: Novel inhibitors of acetylcholinesterase derived from 7-MEOTA - potential Alzheimer´s disease drugs</a><br>
Continuities
P - Projekt vyzkumu a vyvoje financovany z verejnych zdroju (s odkazem do CEP)

Publication year
2013
Confidentiality
S - Úplné a pravdivé údaje o projektu nepodléhají ochraně podle zvláštních právních předpisů

Result description